GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immatics NV (NAS:IMTX) » Definitions » Price-to-Tangible-Book

IMTX (Immatics NV) Price-to-Tangible-Book : 1.76 (As of Dec. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Immatics NV Price-to-Tangible-Book?

As of today (2024-12-15), Immatics NV's share price is $7.21. Immatics NV's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was $4.10. Hence, Immatics NV's Price to Tangible Book Ratio of today is 1.76.

The historical rank and industry rank for Immatics NV's Price-to-Tangible-Book or its related term are showing as below:

IMTX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.76   Med: 3.98   Max: 32.94
Current: 1.76

During the past 6 years, Immatics NV's highest Price to Tangible Book Ratio was 32.94. The lowest was 1.76. And the median was 3.98.

IMTX's Price-to-Tangible-Book is ranked better than
67.3% of 1205 companies
in the Biotechnology industry
Industry Median: 2.81 vs IMTX: 1.76

A closely related ratio is called PB Ratio. As of today, Immatics NV's share price is $7.21. Immatics NV's Book Value per Sharefor the quarter that ended in Sep. 2024 was $4.12. Hence, Immatics NV's P/B Ratio of today is 1.75.


Immatics NV Price-to-Tangible-Book Historical Data

The historical data trend for Immatics NV's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immatics NV Price-to-Tangible-Book Chart

Immatics NV Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial - 6.45 32.94 2.98 3.66

Immatics NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.73 3.66 2.50 2.88 2.78

Competitive Comparison of Immatics NV's Price-to-Tangible-Book

For the Biotechnology subindustry, Immatics NV's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immatics NV's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immatics NV's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Immatics NV's Price-to-Tangible-Book falls into.



Immatics NV Price-to-Tangible-Book Calculation

Immatics NV's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2024 )
=7.21/4.1
=1.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Immatics NV Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Immatics NV's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Immatics NV Business Description

Traded in Other Exchanges
Address
Paul-Ehrlich-Strasse 15, Tubingen, BW, DEU, 72076
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.